|
ARV regimens
|
n/60
|
NAMs nucleoside analogue mutations
|
Thymidine analogue mutations
|
|---|
| | | |
K65R
|
184 V
|
T215Y
|
K70R
|
|---|
|
NNRTI
|
NRTI
| |
R
|
Y/M
|
T/Y
|
R
|
|---|
| | | |
n (%)
|
n (%)
|
n (%)
|
n (%)
|
|---|
|
Efavenz (EFV) containing regiments
| | | | | |
|
EFV
|
TDF/3TC
|
3
|
1 (11.1)
|
1 (33.3)
|
-
|
1 (33.3)
|
| |
AZT/3TC
|
15
|
-
|
5 (33.3)
|
1 (6.7)
|
1 (6.7)
|
|
Total
| |
18
|
1 (5.6)
|
6 (33.3)
|
1 (5.6)
|
2 (11.1)
|
|
Nevirapine (NVP) containing regiments
| | | | | |
|
NVP
|
D4T/3TC
|
4
|
-
|
2 (50)
|
-
|
1 (9.1)
|
| |
TDF/3TC
|
3
|
1 (10)
|
1 (10)
|
-
| |
| |
AZT/3TC
|
18
|
-
|
3 (12.5)
|
2 (8.3)
|
-
|
|
Totals
| |
25
|
1 (3.8)
|
6 (24)
|
2 (7.7)
|
1 (3.8)
|
|
PI
| | | | | | |
|
Lopinavir (LPV)/Ritinovir containing regiments
| | | | | |
|
LPV/R
|
ABC/DDI
|
1
|
-
|
-
|
-
|
-
|
| |
ABC/3TC
|
2
|
-
|
-
|
-
|
-
|
| |
AZT/3TC
|
7
|
-
|
-
|
-
| |
| |
AZT/DDI
|
5
|
-
|
-
|
-
|
-
|
| |
TDF/ABC
|
2
|
-
|
-
|
2 (100)
|
-
|
| |
AZT/TDF/3TC
|
1
|
-
|
-
|
-
|
-
|
|
Sub Total
| |
18
|
-
|
1 (5)
|
2 (10)
|
-
|
|
Totals
| |
60
|
2 (4.7)
|
13 (21.7)
|
5 (7.8)
|
3 (4.7)
|
